{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:52:21Z","timestamp":1790261541576,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jcrc.2020.06.019","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T22:36:17Z","timestamp":1594420577000},"page":"176-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Update I. A systematic review on the efficacy and safety of chloroquine\/hydroxychloroquine for COVID-19"],"prefix":"10.1016","volume":"59","author":[{"given":"Andrea","family":"Cortegiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariachiara","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ingoglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Iozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Giarratano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Einav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2020.06.019_bb0005","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.6019","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review","author":"Sanders","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30172-7","article-title":"Hydroxychloroquine in the management of critically ill patients with COVID-19: The need for an evidence base","author":"Taccone","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0015","article-title":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19","author":"Cortegiani","year":"2020","journal-title":"J Crit Care"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0020","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13054-020-02932-4","article-title":"Chloroquine for COVID-19: Rationale, facts, hopes","volume":"24","author":"Cortegiani","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0025","article-title":"Chapter 24: Including non-randomized studies on intervention effects","author":"Reeves","year":"2019","journal-title":"Cochrane Handb Syst Rev Interv Version 60 (Updated July 2019) Cochrane"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0030","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0035","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0040","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0045","doi-asserted-by":"crossref","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods n.d. https:\/\/doi.org\/10.1002\/jrsm.1411.","DOI":"10.1002\/jrsm.1411"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0050","series-title":"Cochrane Handb Syst Rev Interv Version 60 (Updated July 2019) Cochrane","article-title":"Chapter 12: Synthesizing and presenting findings using other methods | Cochrane Training","author":"Cochrane","year":"2019"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0055","first-page":"1","article-title":"A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19)","volume":"49","author":"Chen","year":"2020","journal-title":"Med Sci"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0060","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2012410","article-title":"Observational study of hydroxychloroquine in hospitalized patients with Covid-19","author":"Geleris","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0065","first-page":"1","article-title":"Treating COVID-19 with chloroquine","volume":"00","author":"Huang","year":"2020","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0070","first-page":"m1844","article-title":"Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data","volume":"2020","author":"Mah\u00e9vas","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0075","first-page":"1","article-title":"Association of Treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State","volume":"12203","author":"Rosenberg","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0080","doi-asserted-by":"crossref","first-page":"m1849","DOI":"10.1136\/bmj.m1849","article-title":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial","volume":"369","author":"Tang","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0085","article-title":"Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19","author":"Yu","year":"2020","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0090","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.8857","article-title":"Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection","volume":"3","author":"Borba","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0095","article-title":"Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France","volume":"101738","author":"Million","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0100","doi-asserted-by":"crossref","first-page":"101663","DOI":"10.1016\/j.tmaid.2020.101663","article-title":"Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study","volume":"34","author":"Gautret","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0105","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.medmal.2020.03.006","article-title":"No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection","volume":"50","author":"Molina","year":"2020","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0110","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.120.048476","article-title":"Association of hydroxychloroquine with QTc interval in patients with COVID-19","author":"Mazzanti","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0115","first-page":"1","article-title":"Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for Coronavirus disease 2019 (COVID-19)","author":"Mercuro","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2020.05.014","article-title":"QT interval prolongation and Torsade De Pointes in patients with COVID-19 treated with hydroxychloroquine\/azithromycin","author":"Chorin","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/jce.14594","article-title":"Incidence and determinants of QT interval prolongation in COVID-19 patients treated with hydroxychloroquine and azithromycin","author":"Maraj","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0130","first-page":"3","article-title":"Assessment of QT intervals in a case series of patients with Coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit","author":"Bessi\u00e8re","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0135","first-page":"1","article-title":"Chloroquine-induced QTc prolongation in COVID-19 patients","author":"van den Broek","year":"2020","journal-title":"Netherlands Heart J"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0140","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.008662","article-title":"The effect of chloroquine, hydroxychloroquine and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection","author":"Saleh","year":"2020","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0145","article-title":"Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend","author":"Peng","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0150","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2016638","article-title":"A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19","author":"Boulware","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0155","doi-asserted-by":"crossref","first-page":"245","DOI":"10.15585\/mmwr.mm6909e1","article-title":"Active monitoring of persons exposed to patients with confirmed COVID-19 - United States, January\u2013February 2020","volume":"69","author":"Burke","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0160","doi-asserted-by":"crossref","DOI":"10.1093\/pubmed\/fdaa074","article-title":"HyPE study: Hydroxychloroquine prophylaxis-related adverse events\u2019 analysis among healthcare workers during COVID-19 pandemic: a rising public health concern","author":"Nagaraja","year":"2020","journal-title":"J Public Health (Bangkok)"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102566","article-title":"Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis","author":"Gendelman","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0170","article-title":"Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS- CoV-2 infection and severe COVID-19","author":"Konig","year":"2020","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0175","article-title":"Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial","author":"Chen","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0180","article-title":"Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients","author":"Carlucci","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0185","article-title":"Treatment response to hydroxychloroquine, lopinavir-ritonavir, and antibiotics for moderate COVID-19: A first report on the pharmacological outcomes from South Korea","author":"Seo Kim","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0190","article-title":"Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19","author":"Magagnoli","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0195","article-title":"Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease: A retrospective study","author":"Mallat","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0200","doi-asserted-by":"crossref","unstructured":"Ramireddy AHC, Reinier K, Ebinger J, Park E, Thompson M, et al. Experience with hydroxychloroquine and azithromycin in the COVID-19 pandemic: Implications for QT interval monitoring. MedRxiv n.d. https:\/\/doi.org\/10.1101\/2020.04.22.20075671.","DOI":"10.1101\/2020.04.22.20075671"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0205","article-title":"Outcomes of hydroxychloroquine treatment among hospitalized COVID-19 patients in the United States- Real-world evidence from a healthcare network for design assistance to complete this project","author":"Singh","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0210","article-title":"Hydroxychloroquine and tocilizumab therapy in COVID-19 patients - An observational study","author":"Ip","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0215","article-title":"Doxycycline and hydroxychloroquine as treatment for high-risk COVID-19 patients: Experience from case series of 54 patients in long-term care facilities","author":"Ahmad","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0220","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1001\/jama.289.19.2554","article-title":"Composite outcomes in randomized trials: greater precision but with greater uncertainty?","volume":"289","author":"Freemantle","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)31023-0","article-title":"Remdesivir for COVID-19: challenges of underpowered studies","author":"Norrie","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0230","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003560","article-title":"Azithromycin causes a novel proarrhythmic syndrome","volume":"10","author":"Yang","year":"2017","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0235","first-page":"155","article-title":"Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reports","volume":"1","author":"Hancox","year":"2013","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0240","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial","volume":"105949","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0245","first-page":"1","article-title":"Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: A multinational registry analysis","volume":"6736","author":"Mehra","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0250","author":"WHO"},{"key":"10.1016\/j.jcrc.2020.06.019_bb0255","unstructured":"Chief Investigators of the Randomised Evaluation of COVid-19 thERapY. No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19 \u2014 RECOVERY Trial n.d. https:\/\/www.recoverytrial.net\/news\/statement-from-the-chief-investigators-of-the-randomised-evaluation-of-covid-19-therapy-recovery-trial-on-hydroxychloroquine-5-june-2020-no-clinical-benefit-from-use-of-hydroxychloroquine-in-hospitalised-patients-with-covid-19 (accessed June 8, 2020)."}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944120306134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944120306134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:44:55Z","timestamp":1760125495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944120306134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":51,"alternative-id":["S0883944120306134"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2020.06.019","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update I. A systematic review on the efficacy and safety of chloroquine\/hydroxychloroquine for COVID-19","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2020.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}